Joint Committee on Vaccination and Immunisation (JCVI)

news

Comirnaty^® authorised for patients six months to four years

7 December 2022 | By Catherine Eckford (European Pharmaceutical Review)

Comirnaty® has been authorised by the MHRA as a vaccine to protect against Covid-19 for individuals from six months to four years old.

news

MHRA approves COVID-19 Vaccine Moderna in 12-17-year olds

18 August 2021 | By Anna Begley (European Pharmaceutical Review)

The MHRA has approved the use of the Spikevax vaccine (formerly COVID-19 Vaccine Moderna) in children aged 12-17 years old.

news

Novavax’ COVID-19 vaccine to be included in UK’s mixed regimen study

15 April 2021 | By Hannah Balfour (European Pharmaceutical Review)

Novavax has agreed to participate in the University of Oxford’s Com-COV2 study evaluating the safety and efficacy of regimens consisting of doses of COVID-19 vaccines from different manufacturers.

news

UK launches trial to study alternating COVID-19 vaccines for different doses

4 February 2021 | By Victoria Rees (European Pharmaceutical Review)

The UK Government has given £7 million of funding for a clinical trial which will investigate whether patients can be given different COVID-19 vaccines for each dose.

news

First patient receives Oxford-AstraZeneca COVID-19 vaccine

4 January 2021 | By Victoria Rees (European Pharmaceutical Review)

Brian Pinker was the first person to receive AZD1222, the COVID-19 vaccine developed by the University of Oxford and AstraZeneca, this morning.